Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Robert W Brueggemeier. (2002) Aromatase inhibitors in breast cancer therapy. Expert Review of Anticancer Therapy 2:2, pages 181-191.
Read now
Read now
Articles from other publishers (21)
Elavarasan Subramani, Arun Prabhu Rameshbabu, Manivannan Jothiramajayam, Bhuvaneshwaran Subramanian, Debangana Chakravorty, Gunja Bose, Mamata Joshi, Chaitali Datta Ray, Indrani Lodh, Ratna Chattopadhyay, Sudipto Saha, Anita Mukherjee, Santanu Dhara, Baidyanath Chakravarty & Koel Chaudhury. (2017) Mycobacterial heat shock protein 65 mediated metabolic shift in decidualization of human endometrial stromal cells. Scientific Reports 7:1.
Crossref
Crossref
Tarun Jha, Nilanajn Adhikari, Amit Kumar Halder & Achintya Saha. 2017. Oncology. Oncology
118
186
.
Tarun Jha, Nilanajn Adhikari, Amit Kumar Halder & Achintya Saha. 2015. Quantitative Structure-Activity Relationships in Drug Design, Predictive Toxicology, and Risk Assessment. Quantitative Structure-Activity Relationships in Drug Design, Predictive Toxicology, and Risk Assessment
400
470
.
Yong Jin An, Hye Rim Cho, Tae Min Kim, Bhumsuk Keam, Jin Wook Kim, He Wen, Chul-Kee Park, Se-Hoon Lee, Seock-Ah Im, Jeong Eun Kim, Seung Hong Choi & Sunghyouk Park. (2015) An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients. International Journal of Cancer 136:1, pages 162-171.
Crossref
Crossref
Yanlei Ma, Peng Zhang, Yongzhi Yang, Feng Wang & Huanlong Qin. (2012) Metabolomics in the fields of oncology: a review of recent research. Molecular Biology Reports 39:7, pages 7505-7511.
Crossref
Crossref
Mohamed-Elamir F. Hegazy, Amira M. Gamal-Eldeen, Ali M. El-Halawany, Abou El-Hamd H. Mohamed & Paul W. Paré. (2012) Steroidal Metabolites Transformed by Marchantia polymorpha Cultures Block Breast Cancer Estrogen Biosynthesis. Cell Biochemistry and Biophysics 63:1, pages 85-96.
Crossref
Crossref
Catherine Oakman, Leonardo Tenori, Laura Biganzoli, Libero Santarpia, Silvia Cappadona, Claudio Luchinat & Angelo Di Leo. (2011) Uncovering the metabolomic fingerprint of breast cancer. The International Journal of Biochemistry & Cell Biology 43:7, pages 1010-1020.
Crossref
Crossref
Paul Goldsmith, Hayley Fenton, Gareth Morris-Stiff, Niaz Ahmad, Julie Fisher & K. Rajendra Prasad. (2010) Metabonomics: A Useful Tool for the Future Surgeon. Journal of Surgical Research 160:1, pages 122-132.
Crossref
Crossref
Carlos Gueto, Juan Torres & Ricardo Vivas-Reyes. (2009) CoMFA, LeapFrog and blind docking studies on sulfonanilide derivatives acting as selective aromatase expression regulators. European Journal of Medicinal Chemistry 44:9, pages 3445-3451.
Crossref
Crossref
Rona Yoffe, Yasmin Khakoo, Ira J. Dunkel, Mark Souweidane, Eric Lis & Charles Sklar. (2005) Recurrent ependymoma treated with high‐dose tamoxifen in a peripubertal female: Impact on tumor and the pituitary–ovarian axis. Pediatric Blood & Cancer 49:5, pages 758-760.
Crossref
Crossref
Nigel J. Gooderham & Paul L. Carmichael. 2005. The Cancer Handbook. The Cancer Handbook.
Maneesh N. Singh, Helen F. Stringfellow, Evangelos Paraskevaidis, Pierre L. Martin-Hirsch & Francis L. Martin. (2007) Tamoxifen: Important considerations of a multi-functional compound with organ-specific properties. Cancer Treatment Reviews 33:2, pages 91-100.
Crossref
Crossref
S.C. Mitchell & P.L. Carmichael. (2005) Metabonomics and the endocrine system. Molecular and Cellular Endocrinology 244:1-2, pages 10-14.
Crossref
Crossref
Robert W. Brueggemeier, John C. Hackett & Edgar S. Diaz-Cruz. (2005) Aromatase Inhibitors in the Treatment of Breast Cancer. Endocrine Reviews 26:3, pages 331-345.
Crossref
Crossref
Nigel J. Gooderham & Paul L. Carmichael. 2005. The Cancer Handbook. The Cancer Handbook.
Jessica C. M. Pole, Leslie I. Gold, Terry Orton, Russell Huby & Paul L. Carmichael. (2005) Gene expression changes induced by estrogen and selective estrogen receptor modulators in primary-cultured human endometrial cells: signals that distinguish the human carcinogen tamoxifen. Toxicology 206:1, pages 91-109.
Crossref
Crossref
Julian L. Griffin & John P. Shockcor. (2004) Metabolic profiles of cancer cells. Nature Reviews Cancer 4:7, pages 551-561.
Crossref
Crossref
Julian L. Griffin. (2004) Metabolic profiles to define the genome: can we hear the phenotypes?. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 359:1446, pages 857-871.
Crossref
Crossref
J.L Griffin, J.C.M Pole, J.K Nicholson & P.L Carmichael. (2003) Cellular environment of metabolites and a metabonomic study of tamoxifen in endometrial cells using gradient high resolution magic angle spinning 1H NMR spectroscopy. Biochimica et Biophysica Acta (BBA) - General Subjects 1619:2, pages 151-158.
Crossref
Crossref
Robert W. Brueggemeier. (2002) Overview of the Pharmacology of the Aromatase Inactivator Exemestane. Breast Cancer Research and Treatment 74:2, pages 177-185.
Crossref
Crossref
Robert W. Brueggemeier. (2001) Aromatase, Aromatase Inhibitors, and Breast Cancer. American Journal of Therapeutics 8:5, pages 333-344.
Crossref
Crossref